03.06.2025 • NewsAsahi KaseiMMARestructuring

Asahi Kasei to Exit MMA and PMMA Businesses

The Japanese chemical group Asahi Kasei has announced that it will end the production of methyl methacrylate (MMA) monomer and other chemicals in Kawasaki City, restructure the site, and focus on its Energy & Infrastructure division.

Asahi Kasei announced on May 27 that it will withdraw from the methyl methacrylate (MMA) monomer, cyclohexyl methacrylate (CHMA), PMMA acrylic resin and SB latex business. Production of these chemicals at the plant in Kawasaki City is scheduled to end between March 2026 and September 2027. The production of acetonitrile at this plant will also be discontinued and all facilities will be restructured. Asahi Kasei expects an extraordinary loss of around 25 billion yen (around €150 million) for the restructuring in the current financial year.

The Japanese chemical group stated that the reason for the production shutdown was that demand had deteriorated due to the expansion of petrochemical products in China and that production of the products in Kawasaki City had therefore become unprofitable and had to be scaled back.

The annual production capacity of the affected products at the Asahi Kasei plant is approximately 100,000 tons for MMA monomers (planned end of production: September 2026), 40,000 tons for PMMA resins (end: September 2026) and 36,000 tons for SB latex (end: September 2027). Acetonitrile production is estimated at 14,000 tons; no figures were provided for CHMA, which is scheduled to be discontinued in March 2026. The date of the end of acetonitrile production will be determined in consultation with customers. Asahi Kasei will continue to produce acetonitrile through its subsidiary in South Korea, which also supplies customers in Japan.

Other jobs will be sought internally for the 190 employees in the affected business.

Following this restructuring, the Kawasaki plant will focus on the production of synthetic rubber such as solution-polymerized styrene-butadiene rubber (S-SBR) and ion exchange membranes, which are seen as the basis for strategic growth areas such as PEM electrolysis and hydrogen production.

Company

Logo:

Asahi Kasei Europe

Fringsstraße 17
40221 Düsseldorf
Germany

Company contact







Free Virtual Event

Vaccine Manufacturing
Bioprocess Forum

Vaccine Manufacturing

Join global experts and innovators for a two-day virtual event exploring the latest breakthroughs and best practices in vaccine manufacturing. Discover how new technologies and process innovations are shaping the future of vaccine production, safety, and scalability.

Interview

Specialty Chemicals in a Shifting World
Adapting to Tariffs and Strengthening Regional Networks

Specialty Chemicals in a Shifting World

Jennifer Abril, President & CEO of SOCMA, discusses the impact of new tariffs and the importance of regional supply networks in the specialty chemical industry.

most read

Photo
22.04.2025 • News

BASF Divests Two Joint Ventures in China

BASF has divested its shares in the joint venture companies, BASF Markor Chemical Manufacturing (Xinjiang) Co., Ltd. and Markor Meiou Chemical (Xinjiang) Co., Ltd. in Korla, China, to Verde Chemical Singapore Pte. Ltd.

Photo
13.03.2025 • News

Roche and Zealand Pharma Collaborate on Weight Management Drug

Swiss pharma heavyweight Roche announced has entered into an exclusive collaboration and licensing agreement with Denmark’s Zealand Pharma. Under the terms of this agreement, the two companies will collaborate to co-develop and co-commercialize petrelintide, Zealand Pharma’s amylin analog as a standalone therapy as well as a fixed-dose combination with Roche’s lead incretin asset CT-388.

Photo
28.07.2025 • NewsChemistry

VCI Welcomes US-EU Customs Deal

The German Chemical Industry Association (VCI) welcomes the fact that Ursula von der Leyen, President of the European Commission, and US President Donald Trump have averted the danger of a trade war for the time being.